IndustryIntelligence | Medicinal Chemicals & Botanical Products

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

We email documents immediately after purchase. Complete your order by clicking the appropriate Buy button. Please ensure your spam filter will not block TCG's email.

$31	Subscribers	2003	Additional Results Support Cancer Trials Strategy	Progen Industries Ltd.
$41	Subscribers Preview	2003	Agreement	Mannatech, Inc.	Baker Botts
$38	Subscribers Preview	2000	Agreement	Charles E. Fioretti	Mannatech, Inc.
$38	Subscribers Preview	2004	Agreement	Savient Pharma; TCG	Schulte Roth
$41	Subscribers	2002	Agreement [Amended] [No. 3]	Mannatech, Inc.
$40	Subscribers	2002	Agreement to Provide Services	Hauser, Inc.
$40	Subscribers	2002	Agreement to Provide Services	Hauser, Inc.
$80	Subscribers Preview	2003	Annual Report to Shareholders	Adaptec; Aeroflex; Affymetrix	AFLAC 2 3 4 5 6 2 3 4 5 6
$99	Subscribers Preview	2003	Annual Report to Shareholders	Adaptec; Aeroflex; Affymetrix	AFLAC 2 3 4 5 6 2 3 4 5 6
$36	Subscribers Preview	2002	Board of Directors Corporate Governance Principles	Neose Technologies, Inc.
$48	Subscribers Preview	2000	Buy Out of Leasehold Interest	KREG-OC L.P.; Pacific View Corporate Center, L.L.C.; Kilroy Realty	Kilroy Realty; NAI; Orrick
$36	Subscribers	2006	Certificate of Merger	Mannatech, Inc.
$33	Subscribers	2005	Certificate of Ownership and Merger	Lynx Therapeutics, Inc.
$41	Subscribers Preview	2002	Collateral Assignment of Trademarks, Trademark Applications, Patents and Patent Applications	Hauser, Inc.	Wells Fargo Bank, NA
$46	Subscribers Preview	2004	Colony Technology Sharing Agreement	Solexa Limited; Cameron McKenna; Lynx	Serono Int'l; Serono
$46	Subscribers	2003	Conference Call	Akzo Nobel; Savient Pharma	TCG
$32	Subscribers	2002	Conference Call	Akzo Nobel N.V.	Savient Pharmaceuticals, Inc.
$42	Subscribers	2003	Conference Call Script	Savient Pharmaceuticals, Inc.	Technology General Corp.
$37	Subscribers Preview	2004	Conference Call Transcript	Savient Pharmaceuticals, Inc.
$35	Subscribers Preview	2004	Conference Call Transcript	Savient Pharmaceuticals, Inc.